🔗 Share this article

A shadow economy for unlicensed weight-loss medications is being driven by social media fitness personalities and vendors on communication apps, based on new investigations.

Experimental Drug Acquiring Popularity Via Social Media

Retatrutide, which is still in clinical trials, is being advertised by social media influencers for its supposed weight-reducing properties. Followers are urged to message these accounts directly for supplier links, while also obtaining promotional offers.

Thriving Commerce on Messaging Platforms

Separately, a robust trade exists on messaging services, where groups with numerous of participants share “before and after” photos, injection guides and assertions of next-day British shipping. Sellers promote the substance there before directing customers to other platforms for purchases.

Understanding Retatrutide

This medication is an experimental injection created by US drugmaker Eli Lilly. The drug affects three gut hormones – glucagon-like peptide-1, GIP and glucagon. Early trials indicate it could help patients reduce up to 25% of their body weight. Referred to as the “triple G”, the substance is being promoted digitally as the next Ozempic.

Healthcare Professionals Express Worries

However, physicians and chemists have warned that the sale of what is still an unapproved drug in the UK is a cause for concern and could lead to users injecting substances of uncertain source.

Several professionals said the demand for retatrutide could be linked to the increasing price of approved slimming products such as Mounjaro.

Legal Status and Implementation

Selling the unapproved drug on social media or Telegram is prohibited in the United Kingdom, as it is an unlicensed drug that must not be promoted or supplied for personal consumption under the Human Medicines Regulations 2012.

Some content creators attempt to sidestep the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled drug, but promotion and supply can still breach medicines, marketing, and customer regulations, potentially leading to fines, legal action or prison.

Platform Response and Content Removal

Based on TikTok, the platform has removed violative content and banned related keywords and query recommendations. The company stated it was committed to keeping the platform secure and investing in enhancing compliance measures.

Online Trading Operations

Research also found groups with up to 9,000 members marketing the experimental drug using the platform's built-in search feature, which functions like a online catalog. Typing “retatrutide” immediately displays groups with thousands of users, filled with images of slimming results, positive reviews and step-by-step guides for preparing or administering at residence.

Within minutes of joining one community, a seller shared WhatsApp details, where most transactions occur. The vendor provided an instruction manual and promised shipping within 48 hours. When questioned whether the substance was genuine, one vendor responded: “You can’t be sure.” Another provided a image of a alleged laboratory certificate. Not one asked about body mass, health issues or past usage.

Product Details and Pricing

Inside these groups, messages show black plastic parcels with Royal Mail stickers, claiming to contain fresh supplies. One message stated: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, mixed at residence with purified liquid, or pre-filled injectors typically priced at £160 for 20 milligrams. When questioned how much time a injector should last, sellers give contradictory responses varying between a several days to “depends on your body”.

Service Moderation and Safety Measures

A spokesperson for the messaging service said it regularly moderated dangerous content on its service including content that promoted the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.

Healthcare Professional Cautions

“People are administering materials they cannot confirm. Even if the science behind this drug is valid, these online versions may not contain what they claim,” stated Jason Murphy, the head of pharmaceutical services at Chemist4U.

A medical professional of an online medical service linked the increase in interest to recent price rises for approved weight-loss drugs such as Mounjaro. “With prices increasing, patients are turning to social media. But counterfeit treatments are extremely dangerous. You cannot know what’s contained or whether the environment they were produced in was sterile,” she explained.

Her team has already encountered patients harmed by self-injection from unconfirmed sources. “We recognize the disappointment, but buying from messaging apps or WhatsApp is taking chances with your well-being,” said the doctor. “These materials could be contaminated or incorrectly dosed.”

Manufacturer Position

A spokesperson from Eli Lilly stated the substance was in phase 3 research studies and had not been reviewed or approved by any government authority anywhere in the world. “Therefore at this time no one can sell [it] for human use,” they said, adding that any item “falsely representing itself as a Lilly investigational product not yet approved … may subject patients to possibly significant health risks”.